Related Experiment Videos
[Efficient fluoride enrichment using mucous membrane adhesives with slow release tablets].
1Klinik für Zahnerhaltung und Parodontologie Aachen.
Summary
Mucoadhesive slow-release devices significantly enhance fluoride bioavailability using low doses. These novel formulations sustain elevated salivary fluoride levels for hours, improving dental health outcomes.
Area of Science:
- Biomaterials Science
- Dental Research
- Pharmacokinetics
Background:
- Conventional fluoride formulations struggle to maintain therapeutic salivary fluoride levels.
- High doses in traditional methods do not guarantee sustained bioavailability.
- Need for improved fluoride delivery systems for enhanced dental care.
Purpose of the Study:
- To investigate the potential of mucoadhesive slow-release devices for enhanced fluoride bioavailability.
- To evaluate the efficacy of different mucoadhesive polymers in sustained fluoride delivery.
- To determine optimal formulations for low-dose, long-duration fluoride release.
Main Methods:
- In vitro and in vivo testing of mucoadhesive polymers including polyacrylic acid, polyethylene glycol, and modified corn starch.
- Formulation of tablets containing 0.1 mg fluoride with selected polymers.
- Measurement of salivary fluoride levels over several hours post-administration.
Main Results:
- Polyethylene glycol (mol. weight 300,000) and a modified starch/polyacrylic acid mixture demonstrated high mucoadhesion and biocompatibility.
- Tablets formulated with these materials effectively sustained elevated salivary fluoride levels.
- Low-dose fluoride (0.1 mg) delivery was achieved with prolonged therapeutic effect.
Conclusions:
- Mucoadhesive slow-release devices offer a promising strategy for enhancing fluoride bioavailability.
- These novel delivery systems can achieve sustained therapeutic fluoride concentrations in saliva with low doses.
- This approach represents a significant advancement in fluoride application for improved dental health.